enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Merck raises outlook for electronics and healthcare, sees ...

    www.aol.com/news/merck-reports-earlier-expected...

    Merck's semiconductor solutions business, which makes up 69% of its electronics business, the smallest of its three divisions that accounts for about 18% of group sales, posted a 10.4% rise in ...

  3. Gold nanoparticles in chemotherapy - Wikipedia

    en.wikipedia.org/wiki/Gold_nanoparticles_in...

    In photothermal cancer therapy, many gold nanoparticle molecules are used in each test and they must all be uniform in size. Including PEG coating, the nanoparticles measured to be ~130 nm in diameter. [1] Gold nanoparticles that act as drug delivery systems in conjugation with chemotherapeutic drugs typically range in size from 10 to 100 nm. [2]

  4. Polyvalent DNA gold nanoparticles - Wikipedia

    en.wikipedia.org/wiki/Polyvalent_DNA_gold...

    Gold nanoparticles can be purchased or synthesized via a variety of methods. [12] Several strategies exist for functionalizing gold nanoparticles with single-stranded DNA; one of the most commonly utilized strategies involves introducing thiol-terminated DNA to a solution of gold nanoparticles and gradually increasing the concentration of a salt, like NaCl.

  5. Merck KGaA suffers major blow as MS drug fails in late-stage ...

    www.aol.com/news/merck-kgaa-suffers-major-blow...

    FRANKFURT (Reuters) -Merck KGaA's experimental multiple sclerosis (MS) drug missed the primary goal in highly anticipated late-stage trials, dealing a major blow to the German company's growth ...

  6. Patritumab deruxtecan - Wikipedia

    en.wikipedia.org/wiki/Patritumab_deruxtecan

    Patritumab deruxtecan (U3-1402/ MK-1022) is an experimental antibody–drug conjugate developed by Merck and Daiichi Sankyo to treat non-small-cell lung cancer. [ 1 ] [ 2 ] [ 3 ] References

  7. UPDATE 1-Orion raises outlook after Merck deal on ... - AOL

    www.aol.com/news/1-orion-raises-outlook-merck...

    Given the upfront payment of $290 million Orion is to receive from Merck, the Finnish company expects sales and operating profit in 2022 to be "clearly higher" than in 2021.

  8. Angela Zhang (scientist) - Wikipedia

    en.wikipedia.org/wiki/Angela_Zhang_(scientist)

    Angela Zhang (born 1994) is an American scientist who in 2009, at the age of fourteen, began to research at Stanford University. [1] [2] By 2011, Zhang's research won the $100,000 Siemens Competition in Math, Science & Technology, and earned her widespread notability [3] [4] [5] for her research on cancer treatments with iron oxide gold nanoparticles.

  9. Merck to buy eye-focused drug developer EyeBio for as ... - AOL

    www.aol.com/news/merck-acquire-eye-drug-company...

    (Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases.